Literature DB >> 23681440

Response: 'Antibody crossreactivity between the tumour suppressor PHLPP1 and the proto-oncogene β-catenin'.

Eric W McIntush.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23681440      PMCID： PMC3674452          DOI： 10.1038/embor.2013.68

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  1 in total

1.  Antibody crossreactivity between the tumour suppressor PHLPP1 and the proto-oncogene β-catenin.

Authors:  Viola H Lobert; Jarle Bruun; Hilde Abrahamsen; Ragnhild A Lothe; Harald Stenmark; Matthias Kolberg; Coen Campsteijn
Journal:  EMBO Rep       Date:  2012-12-11       Impact factor: 8.807
  1 in total
  4 in total

1.  Response to 'How good is research really?'.

Authors:  Alonso Rodríguez-Navarro
Journal:  EMBO Rep       Date:  2013-05-14       Impact factor: 8.807

2.  Detection of PHLPP1α/β in human and mouse brain by different anti-PHLPP1 antibodies.

Authors:  Travis C Jackson; Hülya Bayir; Milos D Ikonomovic; Keri Janesko-Feldman; Zaichuan Mi; Tianyan Gao; Edwin K Jackson; Patrick M Kochanek
Journal:  Sci Rep       Date:  2015-04-01       Impact factor: 4.379

3.  A spatial similarity of stereochemical environments formed by amino acid residues defines a common epitope of two non-homologous proteins.

Authors:  Kentaro Nakashima; Shintaro Iwashita; Takehiro Suzuki; Chieko Kato; Toshiyuki Kohno; Yasutomi Kamei; Motoki Sasaki; Osamu Urayama; Yoshiko Ohno-Iwashita; Naoshi Dohmae; Si-Young Song
Journal:  Sci Rep       Date:  2019-10-15       Impact factor: 4.379

4.  Overcoming off-targets: assessing Western blot signals for Bcnt/Cfdp1, a tentative component of the chromatin remodeling complex.

Authors:  Shintaro Iwashita; Takehiro Suzuki; Yoshimitsu Kiriyama; Naoshi Dohmae; Yoshiharu Ohoka; Si-Young Song; Kentaro Nakashima
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.